Alpha-galactosidase A: TKTX began U.S. Phase II testing

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Product: Alpha-galactosidase A Indication: Treat Fabry disease Status: TKTX began U.S. Phase II testing in 24 patients. The trial should take a ye...